Currently Viewing:
Supplements Standards of Care Issues With Anticoagulation in Real-World Populations
Standards of Care Issues With Anticoagulation in Real-World Populations
Currently Reading
Participating Faculty: Standards of Care Issues With Anticoagulation in Real-World Populations

Participating Faculty: Standards of Care Issues With Anticoagulation in Real-World Populations

This supplement to The American Journal of Managed Care is the second in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE). The focus of this supplement is the issues and complexities surrounding the use of mainstay anticoagulation therapies in real-world populations. Discussions include the impact of comorbidities on international normalized ratio control and the potential impact that population health management and value-based care may have on improving outcomes in NVAF and VTE populations.
Faculty

Jan Berger, MD, MJ—Moderator
President and CEO
Health Intelligence Partners
Chicago, Illinois

Donald C. Balfour III, MD, FACP
President and Medical Director
Sharp Rees-Stealy Medical Group
San Diego, California

Joseph E. Biskupiak, PhD, MBA
Research Professor
Department of Pharmacotherapy
College of Pharmacy, University of Utah
Salt Lake City, Utah

Jeffrey D. Dunn, PharmD, MBA
Senior Vice President
VRx Pharmacy Services, LLC
Salt Lake City, Utah

Dennis B. Liotta, MD, MBA
Former Chief of Pharmacy
EmblemHealth
New York, New York

Adjunct Professor
New York University
Stern School of Business
New York, New York

Geno J. Merli, MD, FACP, FHM, FSVM
Co-Director
Jefferson Vascular Center
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania

Professor of Medicine and Surgery
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, Pennsylvania

Edmund J. Pezalla, MD, MPH
Vice President
National Medical Director
Pharmaceutical Policy and Strategy
Aetna
Hartford, Connecticut

Fadia T. Shaya, PhD, MPH
Professor and Vice-Chair
Director of Research
Center for Innovative Pharmacy Solutions
University of Maryland, School of Pharmacy
Baltimore, Maryland

Tomás Villanueva, DO, MBA, FACPE, SFHM
Assistant Vice President and Medical Director
Baptist Health Medical Group
Miami, Florida


Faculty Disclosures

These faculty report relationships with the following organizations:

Jeffrey D. Dunn, PharmD, MBA
Consultant/paid advisory board: Daiichi Sankyo

Geno J. Merli, MD
Grants: Portola Pharmaceuticals, Inc

Tomás Villanueva, DO, MBA, FACPE, SFHM
Employment: Baptist Health Medical Group
Honoraria: American Regent; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Novo Nordisk

Donald C. Balfour III, MD, FACP; Jan Berger, MD, MJ; Joseph E. Biskupiak, PhD, MBA; Dennis B. Liotta, MD, MBA; Edmund J. Pezalla, MD, MPH; and Fadia T. Shaya, PhD, MPH, have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.
PDF
 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up